Megmazid-T 1.125 gm Injection is used in the treatment of serious bacterial infections, including those caused by resistant organisms in hospital settings. The detailed uses of Megmazid-T 1.125 gm Injection are as follows:&lt;br/&gt;&bull; Treats respiratory infections: Megmazid-T 1.125 gm Injection is effective in managing severe pneumonia, including hospital-acquired cases.&lt;br/&gt;&bull; Manages urinary tract infections: Megmazid-T 1.125 gm Injection is used for complicated UTIs, especially those involving resistant bacterial strains.&lt;br/&gt;&bull; Controls skin and soft tissue infections: Megmazid-T 1.125 gm Injection is indicated for cellulitis, infected wounds, and abscesses.&lt;br/&gt;&bull; Treats intra-abdominal infections: Megmazid-T 1.125 gm Injection is useful in the treatment of serious abdominal infections such as peritonitis.&lt;br/&gt;&bull; Effective against hospital-acquired infections: Megmazid-T 1.125 gm Injection acts against multidrug-resistant bacteria, including ESBL-producing organisms commonly found in hospital settings.&lt;br/&gt;&bull; Enhances antibacterial action: Megmazid-T 1.125 gm Injection provides a synergistic effect by inhibiting bacterial enzymes that break down antibiotics, thereby enhancing overall antibacterial activity against a wide range of gram-positive and gram-negative organisms.&lt;br/&gt;

Medicinal Benefits:

Megmazid-T 1.125 gm Injection contains Ceftazidime and Tazobactam. Ceftazidime works by interfering with the production of the bacterial cell wall (a protective covering required for survival). Tazobactam reduces bacterial resistance and increases the action of Ceftazidime against bacteria. Together, they aid in the treatment of bacterial infections, including serious, life-threatening infections due to gram-positive bacteria.

FAQs

What is the use of Megmazid-T 1.125 gm Injection?

Megmazid-T 1.125 gm Injection is used to treat Bacterial infections.

How does Megmazid-T 1.125 gm Injection work?

Ceftazidime and Tazobactam are both present in Megmazid-T 1.125 gm Injection. Ceftazidime works by preventing the production of the bacterial cell wall (a protective covering required for survival). Tazobactam reduces bacterial resistance while increasing the efficacy of Ceftazidime against bacteria. Together, Megmazid-T 1.125 gm Injection aids in the treatment of bacterial illnesses.

Does Megmazid-T 1.125 gm Injection affect laboratory test results?

Megmazid-T 1.125 gm Injection may Increase liver enzymes. Therefore, if you are about to undergo any laboratory tests, inform your doctor or lab technician that you are taking Megmazid-T 1.125 gm Injection.

Does Megmazid-T 1.125 gm Injection cause diarrhoea?

Megmazid-T 1.125 gm Injection may cause diarrhoea as a common side effect. However, if the condition persists or worsens, consult a doctor immediately.

Is it ideal to take vaccination while on Megmazid-T 1.125 gm Injection therapy?

If you are being treated with Megmazid-T 1.125 gm Injection or have been treated within the last three days, you should talk to your doctor before taking the vaccine. Antibiotics like Megmazid-T 1.125 gm Injection can reduce the vaccine's activity.

How long does Megmazid-T 1.125 gm Injection takes to work?

Megmazid-T 1.125 gm Injection usually begins to work shortly after you start taking it. However, it may take a few days to eliminate all harmful bacteria and improve your symptoms.

What if I don't get better after using Megmazid-T 1.125 gm Injection?

If you do not get better after using Megmazid-T 1.125 gm Injection, reach out to your doctor immediately. They might re-evaluate your condition, investigate potential issues, and modify your treatment accordingly.

What are the side effects of Megmazid-T 1.125 gm Injection?

Megmazid-T 1.125 gm Injection causes side effects such as headache, dizziness, nausea, vomiting, diarrhoea, abdominal pain, muscle spasm, and elevated liver enzymes. Contact a doctor if these side effects persist for longer durations.